- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 14.0392 ↓ -1.41%
[as on 23 January, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| quant Healthcare Fund - Growth Option - Regular Plan | -6.16% | -1.41% | -3.9% | -6.7% | -9.65% | -7.81% | - | - | - | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 78.95% |
6.21% (Arbitrage: 0.00%) |
0.00% |
0.00% |
-3.65% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sequent Scientific Limited | SEQUENT (INE807F01027) | Pharmaceuticals & Biotechnology | 8.26% |
| Zydus Wellness Ltd | ZYDUSWELL (INE768C01028) | Food Products | 7.97% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 7.89% |
| SMS Pharmaceuticals Limited | SMSPHARMA (INE812G01025) | Pharmaceuticals & Biotechnology | 6.53% |
| Pfizer Ltd | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 6.51% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 6.45% |
| ANTHEM BIOSCIENCES LIMITED | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 6.17% |
| Adani Enterprises Limited | ADANIENT (INE423A01024) | Metals & Minerals Trading | 6.14% |
| Alivus Life Sciences | ALIVUS (INE03Q201024) | Pharmaceuticals & Biotechnology | 5.80% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 3.58% |
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 3.40% |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 3.14% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.91% |
| Godrej Properties Limited | GODREJPROP (INE484J01027) | Realty | 2.80% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.41% |
Debt
| Name | Rating | Weight % |
|---|
| 91 Days Treasury Bill 18-Dec-2025 | N.A. | 1.81% |
| 91 Days Treasury Bill 20-Nov-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 28-Nov-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 04-Dec-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 02-Jan-2026 | N.A. | 0.77% |
| 91 Days Treasury Bill 15-Jan-2026 | N.A. | 0.77% |
| 91 Days Treasury Bill 23-Jan-2026 | N.A. | 0.51% |
Portfolio data is as on date 31 October, 2025
NAV (Net asset value) history
quant Healthcare Fund - Growth Option - Regular Plan - 30 days NAV history
| Date | NAV |
|---|
| 23 January, 2026 | 14.0392 |
| 22 January, 2026 | 14.2402 |
| 21 January, 2026 | 14.0042 |
| 20 January, 2026 | 14.1167 |
| 19 January, 2026 | 14.3894 |
| 16 January, 2026 | 14.6092 |
| 14 January, 2026 | 14.7313 |
| 13 January, 2026 | 14.7264 |
| 12 January, 2026 | 14.7798 |
| 9 January, 2026 | 14.8464 |
| 8 January, 2026 | 14.9917 |
| 7 January, 2026 | 15.2812 |
| 6 January, 2026 | 15.2912 |
| 5 January, 2026 | 15.1584 |
| 2 January, 2026 | 15.14 |
| 1 January, 2026 | 14.9608 |
| 31 December, 2025 | 14.9726 |
| 30 December, 2025 | 14.7981 |
| 29 December, 2025 | 14.8204 |
| 26 December, 2025 | 14.9339 |
| 24 December, 2025 | 14.9565 |
| 23 December, 2025 | 15.0473 |
| 22 December, 2025 | 15.1095 |
| 19 December, 2025 | 15.0161 |
| 18 December, 2025 | 14.8669 |
| 17 December, 2025 | 14.9084 |
| 16 December, 2025 | 14.9675 |
| 15 December, 2025 | 15.1144 |
| 12 December, 2025 | 15.1136 |
| 11 December, 2025 | 15.02 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Regular Plan?
The latest NAV of quant Healthcare Fund - Growth Option - Regular Plan is 14.0392 as on 23 January, 2026.
What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Regular Plan?
The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Regular Plan are -6.16% as on 23 January, 2026.
What are 1 year returns of quant Healthcare Fund - Growth Option - Regular Plan?
The 1 year returns of quant Healthcare Fund - Growth Option - Regular Plan are -7.81% as on 23 January, 2026.